14 results on '"Dunson J"'
Search Results
2. Untersuchung von Fetten
- Author
-
Kaufmann, H. P., Baltes, J., van der Hulst, L. J. N., Struszynski, M., Kringstad, H., Kocsis, E. A., Vass, P., Mirer, E., Reith, J. F., van Dijk, C. P., Fink, F., Pijanowski, E., Pyke, M., Mehlenbacher, V. C., Fitelson, J., Siebenberg, W. M., Hubbard, W. S., Neogi, S., Gawler, C. J., Jesser, H., Thomae, E., van Voorst, F. Th., Eisenstein, A., Großfeld, J., Gallup, W. D., Waters, L., Zürn, A., Patzsch, H., Hoton, L., Whitehead, T. H., Dunson, J. B., Wan, C. S., Ho, K., Pollard, C. B., Ellis, L. M., Weltzien, W., Ottensmeyer, H., and Meurice, Ch.
- Published
- 1937
- Full Text
- View/download PDF
3. The Pulse Azimuth effect as seen in induction coil magnetometers located in California and Peru 2007–2010, and its possible association with earthquakes
- Author
-
Dunson, J. C., primary, Bleier, T. E., additional, Roth, S., additional, Heraud, J., additional, Alvarez, C. H., additional, and Lira, A., additional
- Published
- 2011
- Full Text
- View/download PDF
4. Estimation of Oleomargarine in Ice Cream
- Author
-
Whitehead, T. H., primary and Dunson, J. B., additional
- Published
- 1936
- Full Text
- View/download PDF
5. A comparison of crude protein, moisture, ash and crop yield between organic and conventionally grown wheat
- Author
-
Shier, N. W., Kelman, J., and Dunson, J. W.
- Published
- 1984
6. Early experience with a 3-D printed porous surface, fixed-bearing, total ankle arthroplasty: A minimum of 2-year follow-up.
- Author
-
Duff J, Dunson J, and Doty JF
- Subjects
- Humans, Retrospective Studies, Male, Middle Aged, Female, Aged, Follow-Up Studies, Pilot Projects, Adult, Ankle Joint surgery, Ankle Joint diagnostic imaging, Osteoarthritis surgery, Patient Reported Outcome Measures, Porosity, Arthroplasty, Replacement, Ankle instrumentation, Printing, Three-Dimensional, Prosthesis Design, Joint Prosthesis
- Abstract
Background: This is a pilot study reviewing patients undergoing ankle replacement with the 3-D printed INFINITY™ with ADAPTIS™ total ankle arthroplasty (TAA) system., Methods: A retrospective review was conducted of patients with a minimum two-year follow-up who underwent TAA with the INFINITY™ with ADAPTIS™ implant system. Outcome measures include implant survivorship, complications with subsequent reoperations, patient reported outcomes, and radiologic subsidence or radiolucency., Results: Thirty patients were included with median follow-up of 26 months (range, 24-36). Implant survival rate was 90% (27/30). Two patients experienced linear radiolucency > 2 mm: one required a revision TAA secondary to tibial subsidence; the other patient was asymptomatic and nonprogressive on serial radiographs. No cystic radiolucencies > 5 mm were identified. VAS, PROMIS PF, and FADI scores improved significantly., Conclusion: TAA performed with the 3-D printed INFINITY™ with ADAPTIS™ implant technology led to ninety percent short term implant survivorship and improvement in patient reported outcomes with comparable results to other 4th generation arthroplasty systems as a treatment modality for end-stage ankle arthritis., Level of Evidence: Level III, Retrospective cohort study, Prognostic., Competing Interests: Declaration of Competing Interest Dr. Jesse Doty has been a consultant for Arthrex, Inc., Globus Medical Inc., GLW Inc., International Life Sciences, Wright Medical Group, Stryker Corp., Vilex Inc. in roles unrelated to this manuscript. This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors., (Copyright © 2024 European Foot and Ankle Society. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
7. Minimally Invasive Exostectomy for Charcot Neuroarthropathy.
- Author
-
Pate J, Jagiella-Lodise O, Dunson J, and Doty J
- Abstract
Competing Interests: The author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Jesse Doty, MD, reports grants, royalties, and consulting fees from Arthrex. ICMJE forms for all authors are available online.
- Published
- 2024
- Full Text
- View/download PDF
8. Twenty-year survival following lung transplantation.
- Author
-
Miggins JJ, Reul RM Jr, Barrett S, Rana A, Alnajar A, Dunson J, Shafii A, Garcha P, Goss J, and Loor G
- Abstract
Background: Lung transplantation median survival has seen improvements due to recognition of short-term survival factors but continues to trail behind other solid organs due to limited understanding of long-term survivorship. Given the creation of the United Network for Organ Sharing (UNOS) database in 1986, it was difficult to accrue data on long-term survivors until recently. This study characterizes factors impacting lung transplant survival beyond 20 years, conditional to 1-year survival., Methods: Lung transplant recipients listed in UNOS from 1987 to 2002 who survived to 1 post-transplant year were reviewed. Kaplan-Meier and adjusted Cox regression analyses were performed at 20 and 10 years to identify risk factors associated with long-term outcomes independent of their short-term effects., Results: A total of 6,172 recipients were analyzed, including 472 (7.6%) recipients who lived 20+ years. Factors associated with increased likelihood of 20-year survival were female-to-female gender match, recipient age 25-44, waitlist time >1 year, human leukocyte antigen (HLA) mismatch level 3, and donor cause of death: head trauma. Factors associated with decreased 20-year survival included recipient age ≥55, chronic obstructive pulmonary disease/emphysema (COPD/E) diagnosis, donor smoking history >20 pack-years, unilateral transplant, blood groups O&AB, recipient glomerular filtration rate (GFR) <10 mL/min, and donor GFR 20-29 mL/min., Conclusions: This is the first study identifying factors associated with multiple-decade survival following lung transplant in the United States. Despite its challenges, long-term survival is possible and more likely in younger females in good waitlist condition without COPD/E who receive a bilateral allograft from a non-smoking, gender-matched donor of minimal HLA mismatch. Further analysis of the molecular and immunologic implications of these conditions are warranted., Competing Interests: Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-22-1414/coif). GL serves as a consultant and scientific board advisor for TransMedics and Abiomed Breethe, and he receives research grant support from TransMedics, Abiomed Breethe, AtriCure, and the JLH Foundation. The other authors have no conflicts of interest to declare., (2023 Journal of Thoracic Disease. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
9. Recipient Age Predicts 20-Year Survival in Pediatric Liver Transplant.
- Author
-
Keeling S, McDonald MF, Anand A, Dunson J, Williams E, Zhang T, Hickner B, Galván NTN, Mahony CO, Goss JA, and Rana A
- Subjects
- Child, Child, Preschool, Graft Survival, Humans, Living Donors, Retrospective Studies, Survival Rate, Liver Transplantation
- Abstract
Introduction: Pediatric liver transplant recipients have demonstrated excellent long-term survival. The purpose of this analysis is to investigate factors associated with 20-year survival to identify areas for improvement in patient care., Methods: Kaplan-Meier with log-rank test as well as univariate and multivariate logistic regression methods were used to retrospectively analyze 4,312 liver transplant recipients under the age of 18 between September 30, 1987 and March 9, 1998. Our primary endpoint was 20-year survival among one-year survival., Results: Logistic regression analysis identified recipient age as a significant risk factor, with recipients below 5 years old having a higher 20-year survival rate ( p < 0.001). A preoperative primary diagnosis of a metabolic dysfunction was found to be protective compared to other diagnoses (OR 1.64, CI 1.20-2.25). African-American ethnicity (OR 0.71, CI 0.58-0.87) was also found to be a risk factor for mortality. Technical variant allografts (neither living donor nor cadaveric) were not associated with increased or decreased rates of 20-year survival., Conclusions: Our analysis suggests that long-term survival is inversely correlated with recipient age following pediatric liver transplant. If validated with further studies, this conclusion may have profound implications on the timing of pediatric liver transplantation., Competing Interests: The authors declare that they have no conflicts of interest relevant to this article to disclose., (Copyright © 2022 Stephanie Keeling et al.)
- Published
- 2022
- Full Text
- View/download PDF
10. Trends in Survival for Pediatric Transplantation.
- Author
-
Hickner B, Anand A, Godfrey EL, Dunson J, Reul RM, Cotton R, Galvan NTN, O'Mahony C, Goss JA, and Rana A
- Subjects
- Adolescent, Child, Child, Preschool, Female, Follow-Up Studies, Humans, Male, Retrospective Studies, Survival Rate trends, Tissue Donors supply & distribution, Tissue and Organ Procurement methods, Tissue and Organ Procurement trends, Waiting Lists mortality, Heart Transplantation mortality, Heart Transplantation trends, Kidney Transplantation mortality, Kidney Transplantation trends, Liver Transplantation mortality, Liver Transplantation trends
- Abstract
Objectives: Progress in pediatric transplantation measured in the context of waitlist and posttransplant survival is well documented but falls short of providing a complete perspective for children and their families. An intent-to-treat analysis, in which we measure survival from listing to death regardless of whether a transplant is received, provides a more comprehensive perspective through which progress can be examined., Methods: Univariable and multivariable Cox regression was used to analyze factors impacting intent-to-treat survival in 12 984 children listed for heart transplant, 17 519 children listed for liver transplant, and 16 699 children listed for kidney transplant. The Kaplan-Meier method and log-rank test were used to assess change in waitlist, posttransplant, and intent-to-treat survival. Wait times and transplant rates were compared by using χ2 tests., Results: Intent-to-treat survival steadily improved from 1987 to 2017 in children listed for heart (hazard ratio [HR] 0.96, 95% confidence interval [CI] 0.96-0.97), liver (HR 0.95, 95% CI 0.94-0.97), and kidney (HR 0.97, 95% CI 0.95-0.99) transplant. Waitlist and posttransplant survival also improved steadily for all 3 organs. For heart transplant, the percentage of patients transplanted within 1 year significantly increased from 1987 to 2017 (60.8% vs 68.7%); however, no significant increase was observed in liver (68.9% vs 72.5%) or kidney (59.2% vs 62.7%) transplant., Conclusions: Intent-to-treat survival, which is more representative of the patient perspective than individual metrics alone, steadily improved for heart, liver, and kidney transplant over the study period. Further efforts to maximize the donor pool, improve posttransplant outcomes, and optimize patient care while on the waitlist may contribute to future progress., Competing Interests: FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose., (Copyright © 2022 by the American Academy of Pediatrics.)
- Published
- 2022
- Full Text
- View/download PDF
11. Factors associated with long-term graft survival in pediatric kidney transplant recipients.
- Author
-
Anand A, Malik TH, Dunson J, McDonald MF, Christmann CR, Galvan NTN, O'Mahony C, Goss JA, Srivaths PR, Brewer ED, and Rana A
- Subjects
- Adolescent, Age Factors, Child, Child, Preschool, Female, Follow-Up Studies, Health Status Disparities, Humans, Infant, Infant, Newborn, Kaplan-Meier Estimate, Logistic Models, Male, Protective Factors, Retrospective Studies, Risk Factors, Treatment Outcome, Graft Survival, Kidney Failure, Chronic surgery, Kidney Transplantation
- Abstract
Pediatric kidney transplant recipients generally have good outcomes post-transplantation. However, the younger age and longer life span after transplantation in the pediatric population make understanding the multifactorial nature of long-term graft survival critical. This investigation analyzes factors associated with 10-year survival to identify areas for improvement in patient care. Kaplan-Meier with log-rank test and univariable and multivariable logistic regression methods were used to retrospectively analyze 7785 kidney transplant recipients under the age of 18 years from January 1, 1998, until March 9, 2008, using United Network for Organ Sharing (UNOS) data. Our end-point was death-censored 10-year graft survival after excluding recipients whose grafts failed within one year of transplant. Recipients aged 5-18 years had lower 10-year graft survival, which worsened as age increased: 5-9 years (OR: 0.66; CI: 0.52-0.83), 10-14 years (OR: 0.43; CI: 0.33-0.55), and 15-18 years (OR: 0.34; CI: 0.26-0.44). Recipient African American ethnicity (OR: 0.67; CI: 0.58-0.78) and Hispanic donor ethnicity (OR: 0.82; CI: 0.72-0.94) had worse outcomes than other donor and recipient ethnicities, as did patients on dialysis at the time of transplant (OR: 0.82; CI: 0.73-0.91). Recipient private insurance status (OR: 1.35; CI: 1.22-1.50) was protective for 10-year graft survival. By establishing the role of age, race, and insurance status on long-term graft survival, we hope to guide clinicians in identifying patients at high risk for graft failure. This study highlights the need for increased allocation of resources and medical care to reduce the disparity in outcomes for certain patient populations., (© 2021 Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
12. Trends in Outcomes for Marginal Allografts in Liver Transplant.
- Author
-
Zhang T, Dunson J, Kanwal F, Galvan NTN, Vierling JM, O'Mahony C, Goss JA, and Rana A
- Abstract
Importance: Investigating outcomes after marginal allograft transplant is essential in determining appropriate and more aggressive use of these allografts., Objective: To determine the time trends in the outcomes of marginal liver allografts as defined by 6 different sets of criteria., Design, Setting, and Participants: In this case-control, multicenter study, 75 050 patients who received a liver transplant between March 1, 2002, and September 30, 2016, were retrospectively analyzed to last known follow-up (n = 55 395) or death (n = 19 655) using the United Network for Organ Sharing Database. The study period was divided into three 5-year eras: 2002-2006, 2007-2011, and 2012-2016. Kaplan-Meier survival analysis with log-rank test and Cox proportional hazards regression analysis were used to examine the allograft after transplant with marginal allografts, which were defined as 90th percentile Donor Risk Index allografts (calculated over the entire study period), donor after circulatory death allografts, national share allografts, old age (donors >70 years) allografts, fatty liver allografts, and 90th percentile Discard Risk Index allografts. Statistical analysis was performed from August to December 2019., Main Outcomes and Measures: Allograft failure after transplant as defined by the Organ Procurement and Transplantation Network database., Results: Among the 75 050 patients (44 394 men; mean [SD] age, 54.3 [9.9] years) in the study, Donor Risk Index, patient Model for End-stage Liver Disease scores, and balance of risk scores significantly increased over time. Multivariate Cox proportional hazards regression analysis indicated that 90th percentile Donor Risk Index allograft survival increased across the study period (2002-2006: hazard ratio, 1.41 [95% CI, 1.34-1.49]; 2007-2011: hazard ratio, 1.25 [95% CI, 1.17-1.34]; 2012-2016: hazard ratio, 1.10 [95% CI, 0.98-1.24]). Secondary definitions of marginal allografts (donor after circulatory death, national share, old age donors, fatty liver, and 90th percentile Discard Risk Index) showed similar improvements in allograft survival., Conclusions and Relevance: The study's findings encourage the aggressive use of liver allografts and may indicate a need for a redefinition of allograft marginality in liver transplantation.
- Published
- 2020
- Full Text
- View/download PDF
13. Cleaning audits lead to better environmental hygiene.
- Author
-
Appelgate D, Faust B, and Dunson J
- Subjects
- Humans, Infection Control methods, Management Audit methods, Operating Rooms standards, Oregon, Program Evaluation, Health Facility Environment standards, Housekeeping, Hospital standards, Infection Control standards, Management Audit standards, Patient Safety standards
- Published
- 2013
14. Calcium carbonate is an effective phosphorus binder in children with chronic renal failure.
- Author
-
Andreoli SP, Dunson JW, and Bergstein JM
- Subjects
- Adolescent, Alkaline Phosphatase blood, Aluminum Hydroxide therapeutic use, Calcium Carbonate adverse effects, Calcium Carbonate blood, Child, Child, Preschool, Humans, Hypercalcemia blood, Hypercalcemia chemically induced, Infant, Parathyroid Hormone blood, Calcium Carbonate therapeutic use, Kidney Failure, Chronic blood, Phosphorus blood
- Abstract
We evaluated the effectiveness of calcium carbonate as a phosphate binder in 19 children with chronic renal failure; ten children were undergoing dialysis therapy (eight maintained by CAPD and two by hemodialysis). Twelve children had previously received aluminum hydroxide, while calcium carbonate was the primary phosphate binder used in seven children. Among all the children, the serum phosphorus level on no phosphate binder was 7.4 +/- 0.9 mg/dL, which decreased significantly (P less than .001) to 5.9 +/- 0.8 mg/dL during calcium carbonate therapy, while the serum calcium, bicarbonate, and creatinine were unchanged. The reduction in the serum phosphorus level occurred while dietary intake of calcium and phosphorus were unchanged, as demonstrated by three-day dietary records. The dose of calcium carbonate required to maintain the serum phosphorus in the normal range varied from 600 mg to 15 g/d (mean 7.4 g/d). Among the 12 children and four others who had received aluminum hydroxide, serum aluminum levels fell from 108.8 +/- 121.8 ng/mL to 36.1 +/- 29.1 ng/mL after aluminum hydroxide was stopped (P less than .05). Serum alkaline phosphatase and parathyroid hormone (PTH) levels during aluminum hydroxide therapy were similar to levels obtained during calcium carbonate therapy, while PTH levels fell in children treated initially with calcium carbonate. All the children have been observed for a mean of 12.0 months (range 4 months to 3 1/2 years). Hypercalcemia occurred in seven children, usually when vitamin D therapy was initiated or the dose changed. Hypercalcemia resolved with adjustment of the vitamin D or calcium carbonate dose in all but one patient.(ABSTRACT TRUNCATED AT 250 WORDS)
- Published
- 1987
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.